JPS501A - - Google Patents

Info

Publication number
JPS501A
JPS501A JP4884873A JP4884873A JPS501A JP S501 A JPS501 A JP S501A JP 4884873 A JP4884873 A JP 4884873A JP 4884873 A JP4884873 A JP 4884873A JP S501 A JPS501 A JP S501A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4884873A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP4884873A priority Critical patent/JPS501A/ja
Publication of JPS501A publication Critical patent/JPS501A/ja
Pending legal-status Critical Current

Links

Landscapes

  • Separation Of Suspended Particles By Flocculating Agents (AREA)
JP4884873A 1973-04-28 1973-04-28 Pending JPS501A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4884873A JPS501A (pt) 1973-04-28 1973-04-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4884873A JPS501A (pt) 1973-04-28 1973-04-28

Publications (1)

Publication Number Publication Date
JPS501A true JPS501A (pt) 1975-01-06

Family

ID=12814669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4884873A Pending JPS501A (pt) 1973-04-28 1973-04-28

Country Status (1)

Country Link
JP (1) JPS501A (pt)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018191750A2 (en) 2017-04-14 2018-10-18 The Broad Institute Inc. Novel delivery of large payloads
WO2019222555A1 (en) 2018-05-16 2019-11-21 Arbor Biotechnologies, Inc. Novel crispr-associated systems and components
WO2020102610A1 (en) 2018-11-14 2020-05-22 The Broad Institute, Inc. Crispr system based droplet diagnostic systems and methods
WO2021195079A1 (en) 2020-03-23 2021-09-30 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use
EP3889260A1 (en) 2014-12-12 2021-10-06 The Broad Institute, Inc. Protected guide rnas (pgrnas)
EP3929287A2 (en) 2015-06-18 2021-12-29 The Broad Institute, Inc. Crispr enzyme mutations reducing off-target effects
WO2022188039A1 (en) 2021-03-09 2022-09-15 Huigene Therapeutics Co., Ltd. Engineered crispr/cas13 system and uses thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3889260A1 (en) 2014-12-12 2021-10-06 The Broad Institute, Inc. Protected guide rnas (pgrnas)
EP3929287A2 (en) 2015-06-18 2021-12-29 The Broad Institute, Inc. Crispr enzyme mutations reducing off-target effects
WO2018191750A2 (en) 2017-04-14 2018-10-18 The Broad Institute Inc. Novel delivery of large payloads
WO2019222555A1 (en) 2018-05-16 2019-11-21 Arbor Biotechnologies, Inc. Novel crispr-associated systems and components
WO2020102610A1 (en) 2018-11-14 2020-05-22 The Broad Institute, Inc. Crispr system based droplet diagnostic systems and methods
WO2021195079A1 (en) 2020-03-23 2021-09-30 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use
WO2022188039A1 (en) 2021-03-09 2022-09-15 Huigene Therapeutics Co., Ltd. Engineered crispr/cas13 system and uses thereof

Similar Documents

Publication Publication Date Title
AR201758A1 (pt)
AU476761B2 (pt)
AU465372B2 (pt)
AR201235Q (pt)
AR201231Q (pt)
AU474593B2 (pt)
AU474511B2 (pt)
AU474838B2 (pt)
AU471343B2 (pt)
AU465453B2 (pt)
AU465434B2 (pt)
AU450229B2 (pt)
AU476714B2 (pt)
JPS501A (pt)
AR201229Q (pt)
AU476696B2 (pt)
AU472848B2 (pt)
AU466283B2 (pt)
AR199451A1 (pt)
AU477823B2 (pt)
AU477824B2 (pt)
AR200256A1 (pt)
AU471461B2 (pt)
AR200885A1 (pt)
AU476873B1 (pt)